Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland

Heidi Andersén; Pinja Ilmarinen; Jasmin Honkamäki; Leena E. Tuomisto; Päivi Piirilä; Hanna Hisinger-Mölkänen; Anssi Sovijärvi; Helena Backman; Bo Lundbäck; Eva Rönmark; Lauri Lehtimäki; Hannu Kankaanranta

doi:10.1080/20018525.2020.1855702

Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland

Heidi Andersén^*
, Pinja Ilmarinen
, Jasmin Honkamäki
, Leena E. Tuomisto
, Päivi Piirilä
, Hanna Hisinger-Mölkänen
, Anssi Sovijärvi
, Helena Backman
, Bo Lundbäck
, Eva Rönmark
, Lauri Lehtimäki
, Hannu Kankaanranta

^*Tämän työn vastaava kirjoittaja

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

7 Sitaatiot (Scopus)

15 Lataukset (Pure)

Abstrakti

Background Difference in dyspnea mMRC ≥2 between Finnish speaking and Swedish-speaking populations in Finland has not been previously studied. Methods In February 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20–69 years in western Finland with a response rate of 52.3%. The registered native language of each subject determined whether questionnaire in Finnish or Swedish was applied. Multiple logistic regression was performed to calculate Odds Ratios (OR) with 95% CI for the simultaneous effects of independent variables on dyspnea mMRC ≥2. Results Of all participants, 2780 (71.9%) were Finnish speakers and 1084 (28.1%) were Swedish speakers. Finnish speakers had a higher prevalence of dyspnea mMRC ≥2 (11.1% vs 6.5% p < 0.001) when compared to Swedish speakers. Finnish speakers smoked more often, had higher BMI, spent less time moving during the day, had more often occupational exposure to vapours, gases, dusts or fumes (VGDF), and had lower socioeconomic status based on occupation. Significant risk factors for dyspnea mMRC ≥2 were COPD (OR = 10.94), BMI >35 (OR = 9.74), asthma (OR = 4.78), female gender (OR = 2.38), older age (OR = 2.20), current smoking (OR = 1.59), and occupational exposure to VGDF (OR = 1.47). Conclusions Swedish speakers had less dyspnea mMRC ≥2 which is explained by a healthier lifestyle. Smoking, obesity, and occupational exposures should be in focus to improve respiratory health.

Alkuperäiskieli	Englanti
Artikkeli	1855702
Julkaisu	European Clinical Respiratory Journal
Vuosikerta	8
Numero	1
Varhainen verkossa julkaisun päivämäärä	10 jouluk. 2020
DOI - pysyväislinkit	https://doi.org/10.1080/20018525.2020.1855702
Tila	Julkaistu - 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Rahoitus

The authors declare no conflict of interest related to this study. Outside this study, HA reports personal fees from Boehringer Ingelheim, MSD and Roche. Outside this study, PI reports personal fees from MundiPharma, Orion, Astra Zeneca, and GlaxoSmithKline. LET reports non-financial support from Chiesi, non-financial support from Boehringer-Ingelheim, personal fees from Astra Zeneca, non-financial support from Orion Pharma, non-financial support from TEVA and other from Novartis, outside the submitted work. HB reports personal fees from Boehringer–Ingelheim and AstraZeneca outside the submitted work. HHM reports employment at GSK. LL reports personal fees from ALK, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, Orion Pharma, GSK, Teva, Mundipharma, SanofiGenzyme, outside the submitted work. HK report grants, personal fees, and non-financial support from AstraZeneca, personal fees from Chiesi Pharma AB, personal fees, and non-financial support from Boehringer-Ingelheim, personal fees from Novartis, personal fees from Mundipharma, personal fees from Roche, personal fees, and non-financial support from Orion Pharma, personal fees from Sanofi-Genzyme outside the submitted work.

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Julkaisufoorumi-taso

Jufo-taso 1

!!ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Pääsy asiakirjaan

10.1080/20018525.2020.1855702Lisenssi: CC BY-NC

Dyspnea has an association with lifestyle differences between Swedish and Finnish speaking persons in Western FinlandFinal published version, 664 KBLisenssi: CC BY-NC

http://urn.fi/URN:NBN:fi:tuni-202101141304Lisenssi: CC BY-NC

Siteeraa tätä

Andersén, H., Ilmarinen, P., Honkamäki, J., Tuomisto, L. E., Piirilä, P., Hisinger-Mölkänen, H., Sovijärvi, A., Backman, H., Lundbäck, B., Rönmark, E., Lehtimäki, L., & Kankaanranta, H. (2021). Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland. European Clinical Respiratory Journal, 8(1), Artikkeli 1855702. https://doi.org/10.1080/20018525.2020.1855702

@article{cccdead49d294fb8b2ec4abf15fb8cba,

title = "Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland",

abstract = "Background Difference in dyspnea mMRC ≥2 between Finnish speaking and Swedish-speaking populations in Finland has not been previously studied. Methods In February 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20–69 years in western Finland with a response rate of 52.3\%. The registered native language of each subject determined whether questionnaire in Finnish or Swedish was applied. Multiple logistic regression was performed to calculate Odds Ratios (OR) with 95\% CI for the simultaneous effects of independent variables on dyspnea mMRC ≥2. Results Of all participants, 2780 (71.9\%) were Finnish speakers and 1084 (28.1\%) were Swedish speakers. Finnish speakers had a higher prevalence of dyspnea mMRC ≥2 (11.1\% vs 6.5\% p < 0.001) when compared to Swedish speakers. Finnish speakers smoked more often, had higher BMI, spent less time moving during the day, had more often occupational exposure to vapours, gases, dusts or fumes (VGDF), and had lower socioeconomic status based on occupation. Significant risk factors for dyspnea mMRC ≥2 were COPD (OR = 10.94), BMI >35 (OR = 9.74), asthma (OR = 4.78), female gender (OR = 2.38), older age (OR = 2.20), current smoking (OR = 1.59), and occupational exposure to VGDF (OR = 1.47). Conclusions Swedish speakers had less dyspnea mMRC ≥2 which is explained by a healthier lifestyle. Smoking, obesity, and occupational exposures should be in focus to improve respiratory health.",

keywords = "Asthma, COPD, dyspnea, obesity, physical activity, smoking",

author = "Heidi Anders{\'e}n and Pinja Ilmarinen and Jasmin Honkam{\"a}ki and Tuomisto, \{Leena E.\} and P{\"a}ivi Piiril{\"a} and Hanna Hisinger-M{\"o}lk{\"a}nen and Anssi Sovij{\"a}rvi and Helena Backman and Bo Lundb{\"a}ck and Eva R{\"o}nmark and Lauri Lehtim{\"a}ki and Hannu Kankaanranta",

note = "Funding Information: The authors declare no conflict of interest related to this study. Outside this study, HA reports personal fees from Boehringer Ingelheim, MSD and Roche. Outside this study, PI reports personal fees from MundiPharma, Orion, Astra Zeneca, and GlaxoSmithKline. LET reports non-financial support from Chiesi, non-financial support from Boehringer-Ingelheim, personal fees from Astra Zeneca, non-financial support from Orion Pharma, non-financial support from TEVA and other from Novartis, outside the submitted work. HB reports personal fees from Boehringer–Ingelheim and AstraZeneca outside the submitted work. HHM reports employment at GSK. LL reports personal fees from ALK, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, Orion Pharma, GSK, Teva, Mundipharma, SanofiGenzyme, outside the submitted work. HK report grants, personal fees, and non-financial support from AstraZeneca, personal fees from Chiesi Pharma AB, personal fees, and non-financial support from Boehringer-Ingelheim, personal fees from Novartis, personal fees from Mundipharma, personal fees from Roche, personal fees, and non-financial support from Orion Pharma, personal fees from Sanofi-Genzyme outside the submitted work. Publisher Copyright: {\textcopyright} 2020 The Author(s). Published by Informa UK Limited, trading as Taylor \& Francis Group. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",

year = "2021",

doi = "10.1080/20018525.2020.1855702",

language = "English",

volume = "8",

journal = "European Clinical Respiratory Journal",

issn = "2001-8525",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

Andersén, H , Ilmarinen, P, Honkamäki, J, Tuomisto, LE, Piirilä, P, Hisinger-Mölkänen, H, Sovijärvi, A, Backman, H, Lundbäck, B, Rönmark, E, Lehtimäki, L & Kankaanranta, H 2021, 'Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland', European Clinical Respiratory Journal, Vuosikerta 8, Nro 1, 1855702. https://doi.org/10.1080/20018525.2020.1855702

TY - JOUR

T1 - Dyspnea has an association with lifestyle

T2 - differences between Swedish and Finnish speaking persons in Western Finland

AU - Andersén, Heidi

AU - Ilmarinen, Pinja

AU - Honkamäki, Jasmin

AU - Tuomisto, Leena E.

AU - Piirilä, Päivi

AU - Hisinger-Mölkänen, Hanna

AU - Sovijärvi, Anssi

AU - Backman, Helena

AU - Lundbäck, Bo

AU - Rönmark, Eva

AU - Lehtimäki, Lauri

AU - Kankaanranta, Hannu

N1 - Funding Information: The authors declare no conflict of interest related to this study. Outside this study, HA reports personal fees from Boehringer Ingelheim, MSD and Roche. Outside this study, PI reports personal fees from MundiPharma, Orion, Astra Zeneca, and GlaxoSmithKline. LET reports non-financial support from Chiesi, non-financial support from Boehringer-Ingelheim, personal fees from Astra Zeneca, non-financial support from Orion Pharma, non-financial support from TEVA and other from Novartis, outside the submitted work. HB reports personal fees from Boehringer–Ingelheim and AstraZeneca outside the submitted work. HHM reports employment at GSK. LL reports personal fees from ALK, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, Orion Pharma, GSK, Teva, Mundipharma, SanofiGenzyme, outside the submitted work. HK report grants, personal fees, and non-financial support from AstraZeneca, personal fees from Chiesi Pharma AB, personal fees, and non-financial support from Boehringer-Ingelheim, personal fees from Novartis, personal fees from Mundipharma, personal fees from Roche, personal fees, and non-financial support from Orion Pharma, personal fees from Sanofi-Genzyme outside the submitted work. Publisher Copyright: © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.

PY - 2021

Y1 - 2021

N2 - Background Difference in dyspnea mMRC ≥2 between Finnish speaking and Swedish-speaking populations in Finland has not been previously studied. Methods In February 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20–69 years in western Finland with a response rate of 52.3%. The registered native language of each subject determined whether questionnaire in Finnish or Swedish was applied. Multiple logistic regression was performed to calculate Odds Ratios (OR) with 95% CI for the simultaneous effects of independent variables on dyspnea mMRC ≥2. Results Of all participants, 2780 (71.9%) were Finnish speakers and 1084 (28.1%) were Swedish speakers. Finnish speakers had a higher prevalence of dyspnea mMRC ≥2 (11.1% vs 6.5% p < 0.001) when compared to Swedish speakers. Finnish speakers smoked more often, had higher BMI, spent less time moving during the day, had more often occupational exposure to vapours, gases, dusts or fumes (VGDF), and had lower socioeconomic status based on occupation. Significant risk factors for dyspnea mMRC ≥2 were COPD (OR = 10.94), BMI >35 (OR = 9.74), asthma (OR = 4.78), female gender (OR = 2.38), older age (OR = 2.20), current smoking (OR = 1.59), and occupational exposure to VGDF (OR = 1.47). Conclusions Swedish speakers had less dyspnea mMRC ≥2 which is explained by a healthier lifestyle. Smoking, obesity, and occupational exposures should be in focus to improve respiratory health.

AB - Background Difference in dyspnea mMRC ≥2 between Finnish speaking and Swedish-speaking populations in Finland has not been previously studied. Methods In February 2016, a respiratory questionnaire was sent to 8000 randomly selected subjects aged 20–69 years in western Finland with a response rate of 52.3%. The registered native language of each subject determined whether questionnaire in Finnish or Swedish was applied. Multiple logistic regression was performed to calculate Odds Ratios (OR) with 95% CI for the simultaneous effects of independent variables on dyspnea mMRC ≥2. Results Of all participants, 2780 (71.9%) were Finnish speakers and 1084 (28.1%) were Swedish speakers. Finnish speakers had a higher prevalence of dyspnea mMRC ≥2 (11.1% vs 6.5% p < 0.001) when compared to Swedish speakers. Finnish speakers smoked more often, had higher BMI, spent less time moving during the day, had more often occupational exposure to vapours, gases, dusts or fumes (VGDF), and had lower socioeconomic status based on occupation. Significant risk factors for dyspnea mMRC ≥2 were COPD (OR = 10.94), BMI >35 (OR = 9.74), asthma (OR = 4.78), female gender (OR = 2.38), older age (OR = 2.20), current smoking (OR = 1.59), and occupational exposure to VGDF (OR = 1.47). Conclusions Swedish speakers had less dyspnea mMRC ≥2 which is explained by a healthier lifestyle. Smoking, obesity, and occupational exposures should be in focus to improve respiratory health.

KW - Asthma

KW - COPD

KW - dyspnea

KW - obesity

KW - physical activity

KW - smoking

U2 - 10.1080/20018525.2020.1855702

DO - 10.1080/20018525.2020.1855702

M3 - Article

AN - SCOPUS:85097485447

SN - 2001-8525

VL - 8

JO - European Clinical Respiratory Journal

JF - European Clinical Respiratory Journal

IS - 1

M1 - 1855702

ER -

Dyspnea has an association with lifestyle: differences between Swedish and Finnish speaking persons in Western Finland

Abstrakti

Rahoitus

YK:n kestävän kehityksen tavoitteet

Julkaisufoorumi-taso

!!ASJC Scopus subject areas

Pääsy asiakirjaan

Sormenjälki

Siteeraa tätä